GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD

GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD.   The goal of  the new agreement is to develop a small-molecule-based medicine to potentially  reverse FSHD